Zhai P, Eurell T E, Cooke P S, Lubahn D B, Gross D R
Department of Veterinary Biosciences, University of Illinois, Urbana-Champaign, Illinois 61802, USA.
Am J Physiol Heart Circ Physiol. 2000 May;278(5):H1640-7. doi: 10.1152/ajpheart.2000.278.5.H1640.
We investigated the function of estrogen receptor-alpha in global myocardial ischemia and reperfusion injury in male estrogen receptor-alpha knockout (ERKO) and wild-type mice. Mouse hearts were subjected to 45 min of global ischemia followed by 180 min of reperfusion. The hearts were excised, cannulated, and maintained in a chilled (4 degrees C) cardioplegia solution until warm (37 degrees C) oxygenated Krebs-Henseleit bicarbonate buffer was perfused through the coronary arteries. ERKO hearts started beating later and had a higher incidence of ventricular fibrillation and/or tachycardia than control hearts. Coronary flow rate was significantly lower in ERKO hearts during the 90- and 120-min periods of reperfusion. Ca(2+) accumulation was significantly greater following 30, 90, 120, 150, and 180 min of reperfusion in ERKO hearts. Nitrite production was significantly less in ERKO hearts following 90, 120, and 150 min of reperfusion. Myocardial reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide was significantly lower in experimental ERKO hearts. Marked interstitial edema and contraction bands were seen in hematoxylin-eosin-stained sections of ischemia-reperfused ERKO hearts but not in control tissues. Hematoxylin-basic fuchsin-picric acid-stained sections from experimental ERKO hearts had fewer viable myocytes compared with controls. Transmission electron microscopy revealed swollen and fragmented mitochondria with amorphous and granular bodies, loss of matrix, and rupture of cristae in experimental ERKO hearts. This is the first demonstration that estrogen receptor-alpha plays a cardioprotective role in ischemia-reperfusion injury in males.
我们研究了雌激素受体α在雄性雌激素受体α基因敲除(ERKO)小鼠和野生型小鼠的整体心肌缺血及再灌注损伤中的作用。将小鼠心脏进行45分钟的整体缺血,随后进行180分钟的再灌注。取出心脏,插管,并置于冷(4℃)心脏停搏液中,直至通过冠状动脉灌注温热(37℃)的含氧Krebs-Henseleit碳酸氢盐缓冲液。ERKO心脏开始跳动的时间较晚,与对照心脏相比,心室颤动和/或心动过速的发生率更高。在再灌注的90分钟和120分钟期间,ERKO心脏的冠状动脉血流速率显著降低。再灌注30、90、120、150和180分钟后,ERKO心脏中的Ca(2+)积累显著增加。再灌注90、120和150分钟后,ERKO心脏中的亚硝酸盐生成显著减少。实验性ERKO心脏中3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐的心肌还原显著降低。在缺血再灌注的ERKO心脏苏木精-伊红染色切片中可见明显的间质水肿和收缩带,而对照组织中未见。与对照相比,实验性ERKO心脏苏木精-碱性品红-苦味酸染色切片中的存活心肌细胞较少。透射电子显微镜显示,实验性ERKO心脏中的线粒体肿胀、破碎,伴有无定形和颗粒状物质,基质丧失,嵴破裂。这是首次证明雌激素受体α在雄性缺血再灌注损伤中发挥心脏保护作用。